MEEDER ASSET MANAGEMENT INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 809443
DUBLIN, OH
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,528,950
+$1,245,601 QoQ
Shares Held
3,424
+447.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MEEDER ASSET MANAGEMENT INC holds $7,091,404 across 37 Biotechnology names. VRTX ranks #2 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,094 | $4,708,465 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,424 | $1,528,950 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
10,392 | $257,305 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,838 | $103,828 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
9,759 | $87,928 | |
| 6 | VCEL |
Vericel Corp
|
1,900 | $61,123 | |
| 7 | MNPR |
Monopar Therapeutics
|
637 | $34,901 | |
| 8 | ENTA |
Enanta Pharmaceuticals Inc
|
2,025 | $25,575 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,528,950 | 3,424 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $283,349 | 625 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $21,931 | 56 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $24,931 | 56 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $22,786 | 47 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $29,397 | 73 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $33,020 | 71 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $31,872 | 68 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $247,043 | 591 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $211,989 | 521 | Shares | Sole | 2024-01-25 | |
| 2023-06-30 | $3,797,812 | 10,792 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,179,998 | 10,093 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,702,978 | 9,360 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,338,464 | 14,984 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,693,626 | 9,559 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,049,881 | 4,023 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $2,068,568 | 11,404 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $367,571 | 1,823 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $3,389,241 | 15,772 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $366,563 | 1,551 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $4,803,459 | 17,652 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $5,041,519 | 17,366 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,911,180 | 16,437 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||